(-)-epigallocatechin 3-gallate multiple interactions ISO UGCG (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of UGCG mRNA CTD PMID:22079256 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of UGCG mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of UGCG mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO Ugcg (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of UGCG mRNA CTD PMID:25380136 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGCG mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of UGCG mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO UGCG (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of UGCG mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol increases expression ISO UGCG (Homo sapiens) 6480464 Estradiol results in increased expression of UGCG mRNA CTD PMID:19619570 and PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO Ugcg (Rattus norvegicus) 6480464 2 more ... CTD PMID:20959002 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO UGCG (Homo sapiens) 6480464 2 more ... CTD PMID:34627992 2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO UGCG (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of UGCG mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ugcg (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGCG mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ugcg (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of UGCG mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGCG mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO UGCG (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of UGCG mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of UGCG mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO UGCG (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of UGCG mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UGCG mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGCG mRNA more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO UGCG (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGCG mRNA CTD PMID:17101203 2,4-dinitrotoluene affects expression ISO Ugcg (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of UGCG mRNA CTD PMID:21346803 2-palmitoylglycerol increases expression ISO UGCG (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of UGCG mRNA CTD PMID:37199045 3,3',4,4',5-pentachlorobiphenyl increases expression ISO UGCG (Homo sapiens) 6480464 3 more ... CTD PMID:19692669 and PMID:29947894 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Ugcg (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 3,3',5-triiodo-L-thyronine increases activity ISO Ugcg (Rattus norvegicus) 6480464 Triiodothyronine results in increased activity of UGCG protein CTD PMID:9101438 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO UGCG (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UGCG mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Ugcg (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of UGCG mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of UGCG mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO UGCG (Homo sapiens) 6480464 bisphenol S results in decreased expression of UGCG mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol multiple interactions ISO UGCG (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UGCG mRNA CTD PMID:28628672 4-vinylcyclohexene dioxide affects expression EXP 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of UGCG mRNA CTD PMID:20829426 6-propyl-2-thiouracil decreases expression ISO Ugcg (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of UGCG mRNA CTD PMID:30047161 acetamide increases expression ISO Ugcg (Rattus norvegicus) 6480464 acetamide results in increased expression of UGCG mRNA CTD PMID:31881176 all-trans-retinoic acid affects expression ISO UGCG (Homo sapiens) 6480464 Tretinoin affects the expression of UGCG mRNA CTD PMID:15498508 AM-251 decreases expression ISO UGCG (Homo sapiens) 6480464 AM 251 results in decreased expression of UGCG mRNA CTD PMID:16500647 ammonium chloride affects expression ISO Ugcg (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of UGCG mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO UGCG (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of UGCG mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO UGCG (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of UGCG mRNA CTD PMID:33212167 benzo[a]pyrene increases expression ISO UGCG (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of UGCG mRNA CTD PMID:20106945 benzo[a]pyrene increases methylation ISO UGCG (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of UGCG promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Ugcg (Rattus norvegicus) 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:18711122 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of UGCG mRNA CTD PMID:21569818 benzo[a]pyrene decreases expression ISO UGCG (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of UGCG mRNA CTD PMID:20064835 benzo[a]pyrene diol epoxide I decreases expression ISO UGCG (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of UGCG mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions EXP 6480464 AHR protein affects the reaction [beta-Naphthoflavone results in decreased expression of UGCG mRNA] CTD PMID:22234961 beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of UGCG mRNA CTD PMID:22234961 bisphenol A increases expression ISO Ugcg (Rattus norvegicus) 6480464 bisphenol A results in increased expression of UGCG mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO UGCG (Homo sapiens) 6480464 bisphenol A results in increased expression of UGCG mRNA CTD PMID:33670352 bisphenol A affects expression ISO UGCG (Homo sapiens) 6480464 bisphenol A affects the expression of UGCG mRNA CTD PMID:30903817 bleomycin A2 decreases expression ISO UGCG (Homo sapiens) 6480464 Bleomycin results in decreased expression of UGCG mRNA CTD PMID:33770205 bucladesine multiple interactions ISO UGCG (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of UGCG mRNA CTD PMID:20823114 cadmium atom multiple interactions ISO Ugcg (Rattus norvegicus) 6480464 [n-(n-nonyl)-deoxygalactonojirimycin results in decreased activity of UGCG protein] which results in decreased susceptibility to Cadmium CTD PMID:21436125 cadmium dichloride decreases expression ISO Ugcg (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased expression of UGCG mRNA CTD PMID:33453195 cadmium dichloride increases expression ISO UGCG (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of UGCG mRNA CTD PMID:26472689 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of UGCG mRNA CTD PMID:24982889 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of UGCG mRNA CTD PMID:23125180 chromium atom increases expression ISO UGCG (Homo sapiens) 6480464 Chromium results in increased expression of UGCG mRNA CTD PMID:17547211 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of UGCG mRNA CTD PMID:18353800 cocaine increases expression ISO UGCG (Homo sapiens) 6480464 Cocaine results in increased expression of UGCG mRNA CTD PMID:15009677 and PMID:16710320 copper(II) sulfate increases expression ISO UGCG (Homo sapiens) 6480464 Copper Sulfate results in increased expression of UGCG mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO UGCG (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of UGCG mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO UGCG (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of UGCG mRNA CTD PMID:25757056 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of UGCG mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO UGCG (Homo sapiens) 6480464 Cyclosporine results in decreased expression of UGCG mRNA CTD PMID:21632981 dexamethasone increases activity ISO Ugcg (Rattus norvegicus) 6480464 Dexamethasone results in increased activity of UGCG protein CTD PMID:9101438 dexamethasone multiple interactions ISO UGCG (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UGCG mRNA CTD PMID:28628672 diallyl trisulfide increases expression ISO UGCG (Homo sapiens) 6480464 diallyl trisulfide results in increased expression of UGCG mRNA CTD PMID:34995734 dibenz[a,h]anthracene multiple interactions ISO Ugcg (Rattus norvegicus) 6480464 [1 more ... CTD PMID:18711122 dibenzo[a,l]pyrene multiple interactions ISO Ugcg (Rattus norvegicus) 6480464 [1 more ... CTD PMID:18711122 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of UGCG mRNA CTD PMID:21266533 diethylstilbestrol increases activity ISO Ugcg (Rattus norvegicus) 6480464 Diethylstilbestrol results in increased activity of UGCG protein CTD PMID:9101438 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of UGCG mRNA CTD PMID:20880076 dioxygen increases expression ISO UGCG (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of UGCG mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO UGCG (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGCG mRNA CTD PMID:27188386 doxorubicin multiple interactions ISO UGCG (Homo sapiens) 6480464 [N-caproylsphingosine results in increased expression of UGCG mRNA] which results in decreased susceptibility to Doxorubicin more ... CTD PMID:18245173 and PMID:25195822 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of UGCG mRNA CTD PMID:19277126 doxorubicin decreases response to substance ISO UGCG (Homo sapiens) 6480464 UGCG protein results in decreased susceptibility to Doxorubicin CTD PMID:18245173 doxorubicin increases expression ISO UGCG (Homo sapiens) 6480464 Doxorubicin results in increased expression of UGCG mRNA CTD PMID:18245173 doxorubicin decreases expression ISO UGCG (Homo sapiens) 6480464 Doxorubicin results in decreased expression of UGCG mRNA CTD PMID:16404146 and PMID:29803840 elemental selenium multiple interactions ISO UGCG (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of UGCG mRNA CTD PMID:19244175 elemental selenium decreases expression ISO UGCG (Homo sapiens) 6480464 Selenium results in decreased expression of UGCG mRNA CTD PMID:19244175 flavonoids increases expression ISO Ugcg (Rattus norvegicus) 6480464 Flavonoids results in increased expression of UGCG mRNA CTD PMID:18035473 fluoranthene multiple interactions ISO Ugcg (Rattus norvegicus) 6480464 [1 more ... CTD PMID:18711122 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of UGCG mRNA CTD PMID:28329830 fumonisin B1 multiple interactions ISO UGCG (Homo sapiens) 6480464 fumonisin B1 inhibits the reaction [Doxorubicin results in increased expression of UGCG mRNA] CTD PMID:18245173 geldanamycin increases expression ISO UGCG (Homo sapiens) 6480464 geldanamycin results in increased expression of UGCG mRNA CTD PMID:26705709 heroin decreases expression ISO UGCG (Homo sapiens) 6480464 Heroin results in decreased expression of UGCG mRNA CTD PMID:16710320 hexadecanoic acid multiple interactions ISO UGCG (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of UGCG mRNA and [Palmitic Acid co-treated with Oleic Acid] affects the expression of UGCG mRNA CTD PMID:30547786 hydroquinone increases expression ISO UGCG (Homo sapiens) 6480464 hydroquinone results in increased expression of UGCG mRNA CTD PMID:31256213 hypochlorous acid increases expression EXP 6480464 Hypochlorous Acid results in increased expression of UGCG mRNA CTD PMID:19376150 indometacin decreases expression ISO UGCG (Homo sapiens) 6480464 Indomethacin results in decreased expression of UGCG mRNA CTD PMID:16984733 indometacin multiple interactions ISO UGCG (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UGCG mRNA CTD PMID:28628672 leflunomide increases expression ISO UGCG (Homo sapiens) 6480464 leflunomide results in increased expression of UGCG mRNA CTD PMID:28988120 Licochalcone B increases expression ISO UGCG (Homo sapiens) 6480464 licochalcone B results in increased expression of UGCG mRNA CTD PMID:33647349 lithium atom multiple interactions ISO UGCG (Homo sapiens) 6480464 [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of UGCG mRNA CTD PMID:26074776 lithium chloride decreases expression ISO UGCG (Homo sapiens) 6480464 Lithium Chloride results in decreased expression of UGCG mRNA CTD PMID:15711924 lithium chloride multiple interactions ISO UGCG (Homo sapiens) 6480464 [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of UGCG mRNA CTD PMID:26074776 lithium hydride multiple interactions ISO UGCG (Homo sapiens) 6480464 [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of UGCG mRNA CTD PMID:26074776 maneb multiple interactions EXP 6480464 [Maneb co-treated with Paraquat] results in decreased expression of UGCG mRNA CTD PMID:36117858 medroxyprogesterone acetate multiple interactions ISO UGCG (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of UGCG mRNA CTD PMID:20823114 menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of UGCG mRNA CTD PMID:20829426 mercury atom increases expression ISO UGCG (Homo sapiens) 6480464 Mercury results in increased expression of UGCG mRNA CTD PMID:17547211 mercury(0) increases expression ISO UGCG (Homo sapiens) 6480464 Mercury results in increased expression of UGCG mRNA CTD PMID:17547211 methimazole decreases expression ISO Ugcg (Rattus norvegicus) 6480464 Methimazole results in decreased expression of UGCG mRNA CTD PMID:30047161 methotrexate affects response to substance ISO UGCG (Homo sapiens) 6480464 UGCG protein affects the susceptibility to Methotrexate CTD PMID:16217747 methoxychlor affects expression EXP 6480464 Methoxychlor affects the expression of UGCG mRNA CTD PMID:20829426 methoxychlor affects methylation ISO Ugcg (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of UGCG gene CTD PMID:35440735 methylmercury chloride increases expression ISO UGCG (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of UGCG mRNA CTD PMID:28001369 miglustat multiple interactions EXP 6480464 [miglustat results in decreased activity of UGCG protein] which results in decreased abundance of Gangliosides and [miglustat results in decreased activity of UGCG protein] which results in decreased abundance of Glucosylceramides CTD PMID:10037475 mocetinostat increases expression ISO UGCG (Homo sapiens) 6480464 mocetinostat results in increased expression of UGCG mRNA CTD PMID:33770205 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO UGCG (Homo sapiens) 6480464 N more ... CTD PMID:12756304 N-ethyl-N-nitrosourea increases expression ISO Ugcg (Rattus norvegicus) 6480464 Ethylnitrosourea results in increased expression of UGCG mRNA CTD PMID:15954086 N-nitrosodiethylamine increases expression ISO Ugcg (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of UGCG mRNA CTD PMID:20387270 N-nitrosodimethylamine increases expression ISO UGCG (Homo sapiens) 6480464 Dimethylnitrosamine results in increased expression of UGCG mRNA CTD PMID:17547211 oleic acid multiple interactions ISO UGCG (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of UGCG mRNA and [Palmitic Acid co-treated with Oleic Acid] affects the expression of UGCG mRNA CTD PMID:30547786 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of UGCG mRNA CTD PMID:17562736 paracetamol increases expression ISO UGCG (Homo sapiens) 6480464 Acetaminophen results in increased expression of UGCG mRNA CTD PMID:21420995 paraquat multiple interactions EXP 6480464 [Maneb co-treated with Paraquat] results in decreased expression of UGCG mRNA CTD PMID:36117858 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of UGCG mRNA CTD PMID:37995155 perfluorooctanoic acid increases expression ISO Ugcg (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of UGCG mRNA CTD PMID:19162173 phenobarbital affects expression ISO UGCG (Homo sapiens) 6480464 Phenobarbital affects the expression of UGCG mRNA CTD PMID:19159669 phenol increases expression ISO UGCG (Homo sapiens) 6480464 Phenol results in increased expression of UGCG mRNA CTD PMID:17547211 phenylmercury acetate increases expression ISO UGCG (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of UGCG mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO UGCG (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGCG mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of UGCG mRNA CTD PMID:18445702 potassium chromate decreases expression ISO UGCG (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of UGCG mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO UGCG (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of UGCG mRNA CTD PMID:22079256 potassium dichromate increases expression ISO UGCG (Homo sapiens) 6480464 Potassium Dichromate results in increased expression of UGCG mRNA CTD PMID:17547211 progesterone multiple interactions ISO UGCG (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of UGCG mRNA CTD PMID:20660070 quercetin increases expression ISO UGCG (Homo sapiens) 6480464 Quercetin results in increased expression of UGCG mRNA CTD PMID:21632981 resveratrol decreases expression ISO UGCG (Homo sapiens) 6480464 resveratrol results in decreased expression of UGCG and resveratrol results in decreased expression of UGCG mRNA CTD PMID:20401667 and PMID:21500096 rotenone increases expression ISO Ugcg (Rattus norvegicus) 6480464 Rotenone results in increased expression of UGCG mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO UGCG (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGCG mRNA CTD PMID:27188386 selenium atom multiple interactions ISO UGCG (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of UGCG mRNA CTD PMID:19244175 selenium atom decreases expression ISO UGCG (Homo sapiens) 6480464 Selenium results in decreased expression of UGCG mRNA CTD PMID:19244175 silicon dioxide increases expression ISO UGCG (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of UGCG mRNA and Silicon Dioxide results in increased expression of UGCG mRNA CTD PMID:25351596 and PMID:25895662 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of UGCG mRNA CTD PMID:21795629 sulfadimethoxine decreases expression ISO Ugcg (Rattus norvegicus) 6480464 Sulfadimethoxine results in decreased expression of UGCG mRNA CTD PMID:30047161 sunitinib decreases expression ISO UGCG (Homo sapiens) 6480464 Sunitinib results in decreased expression of UGCG mRNA CTD PMID:31533062 tacedinaline increases expression ISO UGCG (Homo sapiens) 6480464 tacedinaline results in increased expression of UGCG mRNA CTD PMID:33770205 tamibarotene affects expression ISO UGCG (Homo sapiens) 6480464 tamibarotene affects the expression of UGCG mRNA CTD PMID:15498508 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of UGCG mRNA CTD PMID:20937368 temozolomide increases expression ISO UGCG (Homo sapiens) 6480464 Temozolomide results in increased expression of UGCG mRNA CTD PMID:31758290 testosterone enanthate affects expression ISO UGCG (Homo sapiens) 6480464 testosterone enanthate affects the expression of UGCG mRNA CTD PMID:17440010 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of UGCG mRNA CTD PMID:27339419 and PMID:31919559 tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of UGCG mRNA CTD PMID:16917069 thimerosal decreases expression ISO UGCG (Homo sapiens) 6480464 Thimerosal results in decreased expression of UGCG mRNA CTD PMID:27188386 thioacetamide increases expression ISO Ugcg (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of UGCG mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of UGCG mRNA CTD PMID:23557971 topotecan increases expression ISO Ugcg (Rattus norvegicus) 6480464 Topotecan results in increased expression of UGCG mRNA CTD PMID:25729387 trichloroethene decreases expression ISO Ugcg (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of UGCG mRNA CTD PMID:33387578 trichostatin A increases expression ISO UGCG (Homo sapiens) 6480464 trichostatin A results in increased expression of UGCG mRNA CTD PMID:26705709 trichostatin A affects expression ISO UGCG (Homo sapiens) 6480464 trichostatin A affects the expression of UGCG mRNA CTD PMID:28542535 urethane increases expression ISO UGCG (Homo sapiens) 6480464 Urethane results in increased expression of UGCG mRNA CTD PMID:28818685 valproic acid decreases expression ISO UGCG (Homo sapiens) 6480464 Valproic Acid results in decreased expression of UGCG mRNA CTD PMID:23179753 and PMID:27188386 valproic acid increases expression ISO UGCG (Homo sapiens) 6480464 Valproic Acid results in increased expression of UGCG mRNA CTD PMID:28001369 vincristine increases expression ISO UGCG (Homo sapiens) 6480464 Vincristine results in increased expression of UGCG mRNA CTD PMID:23649840 vitamin E multiple interactions ISO UGCG (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of UGCG mRNA CTD PMID:19244175 vitamin E decreases expression ISO UGCG (Homo sapiens) 6480464 Vitamin E results in decreased expression of UGCG mRNA CTD PMID:19244175 vorinostat increases expression ISO UGCG (Homo sapiens) 6480464 Vorinostat results in increased expression of UGCG mRNA CTD PMID:33770205 vorinostat decreases expression ISO UGCG (Homo sapiens) 6480464 vorinostat results in decreased expression of UGCG mRNA CTD PMID:27188386 zinc atom multiple interactions ISO UGCG (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of UGCG mRNA CTD PMID:18593933 zinc sulfate increases expression ISO UGCG (Homo sapiens) 6480464 Zinc Sulfate results in increased expression of UGCG mRNA CTD PMID:12756304 zinc(0) multiple interactions ISO UGCG (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of UGCG mRNA CTD PMID:18593933